ask="N/A"
ask_size="N/A"
average_daily_volume="36443"
bid="3.7500"
bid_size="1600"
book_value="2.2000"
change="+0.1100"
change_from_200_day_moving_average="1.8505"
change_from_50_day_moving_average="1.0031"
change_from_52_week_high="-1.6001"
change_From_52_week_low="2.7599"
change_in_percent="+1.9333%"
close="5.7999"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.8000"
ebitda="-3.26M"
eps_estimate_current_year="-0.0200"
eps_estimate_next_quarter="0.0000"
eps_estimate_next_year="-0.0200"
ex_dividend_date="N/A"
float_shares="3212000"
high="5.9000"
high_52_weeks="7.4000"
last_trade_date="2/22/2017"
last_trade_price="5.7999"
last_trade_size="200"
last_trade_time="3:58pm"
low="5.7500"
low_52_weeks="3.0400"
market_capitalization="19.59M"
moving_average_200_day="3.9494"
moving_average_50_day="4.7968"
name="BiondVax Pharmaceuticals Ltd."
notes="N/A"
one_year_target_price="15.0000"
open="5.8000"
pe_ratio="N/A"
peg_ratio="0.0000"
percent_change_from_200_day_moving_average="+46.8556%"
percent_change_from_50_day_moving_average="+20.9129%"
percent_change_from_52_week_high="-21.6230%"
percent_change_from_52_week_low="+90.7862%"
previous_close="5.6899"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.5863"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="3377000"
short_ratio="0.2600"
stock_exchange="NCM"
symbol="BVXV"
volume="16319"
weeks_range_52="3.0400 - 7.4000"
